HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Geffin, G. A. Articles by Daggett, W. M. Search for Related Content PubMed PubMed Citation Articles by Geffin, G. A. Articles by Daggett, W. M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 98, 239-250, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

The effects of calcium and magnesium in hyperkalemic cardioplegic solutions on myocardial preservation

GA Geffin, TR Love, WG Hendren, DF Torchiana, JS Titus, BE Redonnett, DD O'Keefe and WM Daggett
Department of Surgery, Massachusetts General Hospital, Boston 02114.

Sustained left ventricular pressure development during each infusion of a cold calcium-containing hyperkalemic cardioplegic solution has been observed in rat hearts. The present study was undertaken to relate such contraction (i.e., increase in resting pressure) to myocardial preservation and to the calcium and magnesium contents of a crystalloid hyperkalemic cardioplegic solution. Isolated perfused rat hearts with a left ventricular isovolumic balloon were arrested at 8 degrees C by the fully oxygenated cardioplegic solution infused every 15 minutes for 2 hours. Cardioplegic solutions containing ionized calcium in concentrations of 0, 0.1, or 1.2 mmol/L were each studied with (groups 2, 4, and 6) and without (groups 1, 3, and 5) the addition of magnesium (16 mmol/L). Hearts arrested by the cardioplegic solution with no calcium or magnesium (group 1) developed a pressure (averaged over the second to eighth infusion and expressed as percent prearrest left ventricular pressure) of 6.0% +/- 0.4% during cardioplegic infusions. This solution maintained end-arrest myocardial adenosine triphosphate (13.1 +/- 1.0 nmol/mg dry weight) and phosphocreatine (21.7 +/- 2.8 nmol/mg dry weight) contents near the prearrest contents and preserved left ventricular function at 95% +/- 3% of prearrest developed left ventricular pressure at 15 minutes of reperfusion at 37 degrees C. Calcium (groups 3 and 5) increased pressure development during cardioplegic infusions (10.4% +/- 0.5% and 15.1% +/- 0.9%), depleted adenosine triphosphate (7.2 +/- 1.0 and 7.4 +/- 0.9) and phosphocreatine (13.3 +/- 1.8 and 10.7 +/- 1.5), and depressed left ventricular functional recovery (71% +/- 1% and 73% +/- 3%). Magnesium alone (group 2) decreased pressure development during cardioplegic infusions (3.0% +/- 0.3%), maintained adenosine triphosphate (15.6 +/- 0.9), augmented phosphocreatine (38.3 +/- 1.2), and preserved left ventricular function (99% +/- 4%). Magnesium added to calcium (groups 4 and 6) prevented the calcium-induced increased pressure development during cardioplegic infusions (4.0% +/- 0.5% and 6.7% +/- 0.6%), maintained adenosine triphosphate (13.6 +/- 1.4 and 14.9 +/- 0.7), augmented phosphocreatine (31.3 +/- 1.6 and 32.2 +/- 2.4), and ameliorated the depression of functional recovery (82% +/- 2% and 86% +/- 2%). These data suggest that left ventricular pressure development during arrest contributed to calcium-induced energy depletion and impairment of functional recovery and that these deleterious effects were inhibited by magnesium. The inhibitory effects of magnesium on left ventricular pressure development were rapidly reversed on reperfusion. The data support the addition

This article has been cited by other articles:

				J. An, A. K.S. Camara, Q. Chen, and D. F. Stowe Effect of low [CaCl2] and high [MgCl2] cardioplegia and moderate hypothermic ischemia on myoplasmic [Ca2+] and cardiac function in intact hearts Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 974 - 985. [Abstract] [Full Text] [PDF]

				D. F. Stowe, S. G. Varadarajan, J. An, and S. C. Smart Reduced Cytosolic Ca2+ Loading and Improved Cardiac Function After Cardioplegic Cold Storage of Guinea Pig Isolated Hearts Circulation, September 5, 2000; 102(10): 1172 - 1177. [Abstract] [Full Text] [PDF]

				D. F. Torchiana, A. J. Vine, K. O. Shebani, H. L. Kantor, J. S. Titus, C.-Z. Lu, W. M. Daggett, and G. A. Geffin Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy Ann. Thorac. Surg., July 1, 2000; 70(1): 197 - 205. [Abstract] [Full Text] [PDF]

				N. Matsuda, M. Tofukuji, K. G. Morgan, and F. W. Sellke Coronary microvascular protection with Mg2+: effects on intracellular calcium regulation and vascular function Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1124 - H1130. [Abstract] [Full Text] [PDF]

				J. R. Lopez, R. Jahangir, A. Jahangir, W. K. Shen, and A. Terzic POTASSIUM CHANNEL OPENERS PREVENT POTASSIUM-INDUCED CALCIUM LOADING OF CARDIAC CELLS: POSSIBLE IMPLICATIONS IN CARDIOPLEGIA J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 820 - 831. [Abstract] [Full Text]

				C. M. R. Satur, S. R. Stubington, A. Jennings, K. Newton, P. G. Martin, C. Gebitekin, and D. R. Walker Magnesium Flux During and After Open Heart Operations in Children Ann. Thorac. Surg., April 1, 1995; 59(4): 921 - 927. [Abstract] [Full Text]

				J. Caspi, E. Rudis, I. Bar, T. Safadi, and M. Saute Effects of Magnesium on Myocardial Function After Coronary Artery Bypass Grafting Ann. Thorac. Surg., April 1, 1995; 59(4): 942 - 947. [Abstract] [Full Text]